Synonyms: ATI-501 | ATI50001 | ATI501 | example 103 [WO2007070872A1]
Compound class:
Synthetic organic
Comment: ATI-50001 (ATI-501) is an orally bioactive kinase inhibitor, with selectivity for Janus kinases (JAK) 1/3. It was claimed in Rigel Pharmaceuticals' 2007 patent WO2007070872A1 [1], but it was later developed by Aclaris Therapeutics.
|
|
References |
1. Ding P, Argade A, Goff D, Singh R, Masuda E, Taylor V, Holland S. (2007)
Kinase inhibitors and their uses. Patent number: WO2007070872A1. Assignee: Rigel Pharmaceuticals, Inc.. Priority date: 15/12/2006. Publication date: 21/06/2007. |